UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Journal for immunotherapy of cancer, 2019-02, Vol.7 (1), p.33-16, Article 33

2019

Volltextzugriff (PDF)

P2.18-02 Successful Generation of Tumor-Infiltrating Lymphocytes (TIL) for Adoptive Cell Therapy from Mesothelioma

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S381-S382

2023

Volltextzugriff (PDF)

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

Haematologica (Roma), 2012-12, Vol.97 (12), p.1882-1889

2012

Volltextzugriff (PDF)

High Frequency of Alloantigen-Specific T-Regs in Human Blood Allow Rapid Ex Vivo Expansion for Adoptive Therapy

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S168-S168

2011

Volltextzugriff (PDF)

Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

Blood, 2011-11, Vol.118 (20), p.5671-5680

2011

Volltextzugriff (PDF)

Influence of Steel Slag Aggregates on Impact Strength and Abrasion Resistance of Concrete Pavement

International journal of engineering and advanced technology, 2019-12, Vol.9 (2), p.4686-4688

2019

Volltextzugriff (PDF)

STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity

Journal of leukocyte biology, 2014-02, Vol.95 (2), p.205-213

2014

Volltextzugriff (PDF)

Biosorption of Malachite Green from Aqueous Phase by Tamarind Fruit Shells Using FBR

Advances in materials science and engineering, 2022, Vol.2022, p.1-7

2022

Volltextzugriff (PDF)

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation

Proceedings of the National Academy of Sciences - PNAS, 2018-02, Vol.115 (7), p.1582-1587

2018

Volltextzugriff (PDF)

Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis

PLoS neglected tropical diseases, 2009-06, Vol.3 (6), p.e457-e457

2009

Volltextzugriff (PDF)

HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease

The Journal of immunology (1950), 2015-07, Vol.195 (2), p.717-725

2015

Volltextzugriff (PDF)

Abstract A05: Expansion of tumor-infiltrating lymphocytes (TIL) using Iovance's Gen 2 process from advanced bladder cancer for adoptive immunotherapy

Clinical cancer research, 2020-08, Vol.26 (15_Supplement), p.A05-A05

2020

Volltextzugriff (PDF)

Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy

Journal of immunotherapy (1997), 2024-11, Vol.47 (9), p.361-368

2024

Volltextzugriff (PDF)

K+ Channel Activation Promotes Tumor infiltrating Lymphocyte (TIL) Expansion and Enhances Expression of CCR7

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.198-198.1

2017

Volltextzugriff (PDF)

Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining T reg and antitumor CTL function

Science translational medicine, 2017-01, Vol.9 (372)

2017

Volltextzugriff (PDF)

T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data

PloS one, 2008-03, Vol.3 (3), p.e1850-e1850

2008

Volltextzugriff (PDF)

Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function

Science translational medicine, 2017-01, Vol.9 (372)

2017

Volltextzugriff (PDF)

CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response

Journal of leukocyte biology, 2015-04, Vol.97 (4), p.807-819

2015

Volltextzugriff (PDF)

176 Successful generation of tumor-infiltrating lymphocyte (TIL) product from renal cell carcinoma (RCC) tumors for adoptive cell therapy

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A188-A188

2021

Volltextzugriff (PDF)

Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease

Blood, 2013-09, Vol.122 (13), p.2251-2261

2013

Volltextzugriff (PDF)

Abstract 2746: Preclinical activity and manufacturing feasibility of genetically modified PDCD-1 knockout (KO) tumor-infiltrating lymphocyte (TIL) cell therapy

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2746-2746

2022

Volltextzugriff (PDF)

Error Recursion Reduction Computational Technique Based Control System Design for a Multivariable Process

Instrumentation Mesure Métrologie, 2020-04, Vol.19 (2), p.133-140

2020

Volltextzugriff (PDF)

CD4 Treg and CD4 Tcon Utilize Distinct TCR Vbeta Repertoires in Response to Alloantigen

Blood, 2015-12, Vol.126 (23), p.4286-4286

2015

Volltextzugriff (PDF)

Characteristics and Operations of Complex Fuzzy Graphs

International Journal of Information Technology, Research and Applications, 2023-06, Vol.2 (2), p.47-53

2023

Volltextzugriff (PDF)

Efficacy of single administration of tumor-infiltrating lymphocytes (TIL) in heavily pretreated patients with metastatic melanoma following checkpoint therapy

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3045-3045

2017

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Humans
(10)
Animals
(7)
Female
(7)
Immunology
(7)
Male
(7)
Graft Vs Host Disease - Prevention & Control
(6)
Hematology
(5)
Mice
(5)
T-Lymphocytes, Regulatory - Cytology
(5)
T-Lymphocytes, Regulatory - Immunology
(5)
Lymphocytes
(4)
Biological And Medical Sciences
(3)
Cell Biology
(3)
Experiments
(3)
Genetic Aspects
(3)
Graft Vs Host Disease - Immunology
(3)
Health Aspects
(3)
Hematology, Oncology And Palliative Medicine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

P2.18-02 Successful Generation of Tumor-Infiltrating Lymphocytes (TIL) for Adoptive Cell Therapy from Mesothelioma

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

High Frequency of Alloantigen-Specific T-Regs in Human Blood Allow Rapid Ex Vivo Expansion for Adoptive Therapy

Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

Influence of Steel Slag Aggregates on Impact Strength and Abrasion Resistance of Concrete Pavement

STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity

Biosorption of Malachite Green from Aqueous Phase by Tamarind Fruit Shells Using FBR

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation

Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis

HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease

Abstract A05: Expansion of tumor-infiltrating lymphocytes (TIL) using Iovance's Gen 2 process from advanced bladder cancer for adoptive immunotherapy

Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy

K+ Channel Activation Promotes Tumor infiltrating Lymphocyte (TIL) Expansion and Enhances Expression of CCR7

Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining T reg and antitumor CTL function

T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data

Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function

CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response

176 Successful generation of tumor-infiltrating lymphocyte (TIL) product from renal cell carcinoma (RCC) tumors for adoptive cell therapy

Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease

Abstract 2746: Preclinical activity and manufacturing feasibility of genetically modified PDCD-1 knockout (KO) tumor-infiltrating lymphocyte (TIL) cell therapy

Error Recursion Reduction Computational Technique Based Control System Design for a Multivariable Process

CD4 Treg and CD4 Tcon Utilize Distinct TCR Vbeta Repertoires in Response to Alloantigen

Characteristics and Operations of Complex Fuzzy Graphs

Efficacy of single administration of tumor-infiltrating lymphocytes (TIL) in heavily pretreated patients with metastatic melanoma following checkpoint therapy

Suchergebnisse filtern